Skip navigation
中文
English
DSpace
CRIS
首頁
單位
研究人員
研究成果檢索
分類瀏覽
單位
研究人員
研究成果檢索
學術出版
幫助
登入
中文
English
NTU Scholars
研究成果檢索
瀏覽 的方式: 作者
Ling M.
或是輸入前幾個字:
跳到:
0-9
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
排序方式:
升冪
降冪
結果/頁面
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
作者/紀錄:
全部
1
5
10
15
20
25
30
35
40
45
50
顯示 1 到 14 筆資料,總共 14 筆
公開日期
標題
作者
來源出版物
scopus
WOS
全文
2001
Cancer immunotherapy using a DNA vaccine encoding the translocation domain of a bacterial toxin linked to a tumor antigen
Hung C.-F.; WEN-FANG CHENG
; Hsu K.-F.; Chai C.-Y.; He L.; Ling M.; Wu T.-C.
Cancer Research
0
2002
Cancer immunotherapy using sindbis virus replicon particles encoding a VP22-antigen fusion
WEN-FANG CHENG
; Hung C.-F.; Hsu K.-F.; Chai C.-Y.; He L.; Polo J.M.; Slater L.A.; Ling M.; Wu T.-C.
Human Gene Therapy
115
103
2003
CD8+ T cells, NK cells and IFN-γ are important for control of tumor with downregulated MHC class I expression by DNA vaccination
WEN-FANG CHENG
; Hung C.F.; Lin K.Y.; Ling M.; Juang J.; He L.; Lin C.T.; Wu T.-C.
Gene Therapy
55
49
2001
Enhancement of DNA vaccine potency by linkage of antigen gene to a gene encoding the extracellular domain of Fms-like tyrosine kinase 3-ligand
Hung C.-F.; Hsu K.-F.; WEN-FANG CHENG
; Chai C.-Y.; He L.; Ling M.; Wu T.-C.
Cancer Research
0
2001
Enhancement of Sindbis virus self-replicating RNA vaccine potency by linkage of herpes simplex virus type 1 VP22 protein to antigen
WEN-FANG CHENG
; Hung C.-F.; Chai C.-Y.; Hsu K.-F.; He L.; Ling M.; Wu T.-C.
Journal of Virology
79
64
2001
Enhancement of sindbis virus self-replicating RNA vaccine potency by linkage of Mycobacterium tuberculosis heat shock protein 70 gene to an antigen gene
WEN-FANG CHENG
; Hung C.-F.; Chai C.-Y.; Hsu K.-F.; He L.; Rice C.M.; Ling M.; Wu T.-C.
Journal of Immunology
66
56
2001
Enhancement of sindbis virus self-replicating RNA vaccine potency by targeting antigen to endosomal/lysosomal compartments
WEN-FANG CHENG
; Hung C.-F.; Hsu K.-F.; Chai C.-Y.; He L.; Ling M.; Slater L.A.; Roden R.B.S.; Wu T.-C.
Human Gene Therapy
67
61
2001
Enhancement of suicidal DNA vaccine potency by linking Mycobacterium tuberculosis heat shock protein 70 to an antigen
Hsu K.-F.; Hung C.-F.; WEN-FANG CHENG
; He L.; Slater L.A.; Ling M.; Wu T.-C.
Gene Therapy
115
96
2003
Enhancing major histocompatibility complex class I antigen presentation by targeting antigen to centrosomes
Hung C.-F.; WEN-FANG CHENG
; He L.; Ling M.; Juang J.; Lin C.-T.; Wu T.-C.
Cancer Research
0
2018
Hydrogen production from algal biomass – Advances, challenges and prospects
Show K.-Y.; Yan Y.; Ling M.; Ye G.; Li T.; Lee D.-J.
Bioresource Technology
127
98
2001
Improving vaccine potency through intercellular spreading and enhanced MHC class I presentation of antigen
Hung C.-F.; WEN-FANG CHENG
; Chai C.-Y.; Hsu K.-F.; He L.; Ling M.; Wu T.-C.
Journal of Immunology
131
114
2001
Recombinant DNA vaccines protect against tumors that are resistant to recombinant vaccinia vaccines containing the same gene
CHIEN-HUNG CHEN
; Wang T.-L.; Ji H.; Hung C.-F.; Pardoll D.M.; WEN-FANG CHENG
; Ling M.; Wu T.-C.
Gene Therapy
21
22
2002
Repeated DNA vaccinations elicited qualitatively different cytotoxic T lymphocytes and improved protective antitumor effects
WEN-FANG CHENG
; Hung C.F.; Pai S.I.; Hsu K.F.; He L.; Ling M.; Wu T.C.
Journal of biomedical science
24
0
2001
Tumor-specific immunity and antiangiogenesis generated by a DNA vaccine encoding calreticulin linked to a tumor antigen
WEN-FANG CHENG
; Hung C.-F.; Chai C.-Y.; Hsu K.-F.; He L.; Ling M.; Wu T.-C.
Journal of Clinical Investigation
250
0